ZoomInfo Technologies enters its May 14 earnings report with options traders unusually bullish — and a significant short position still to be convinced.
The clearest positioning signal is in options. The put/call ratio has collapsed to 0.28, nearly a full standard deviation below its 20-day average of 0.44. That's an unusually call-heavy skew, pointing to demand for upside exposure rather than downside protection. The contrast with mid-April is stark: the PCR ran above 0.70 for much of that period, when the stock was trading near its lows. Since then, GTM climbed roughly 15% over the past month — touching $6.04 after recovering from lows near $5.23 — before giving back 7% in the past week alone, including a 5.3% drop on Monday.
Short interest remains elevated but has eased at the margin. At 12.7% of the free float, bears hold a meaningful position — yet shares short have dipped about 0.5% over the past week and are down from a recent peak near 41 million shares. The borrow market is loose. Cost to borrow is just 0.46%, barely changed in a month, and availability is ample, suggesting the short side is not scrambling for shares. The ORTEX short score of 55.8 reflects moderate-but-not-extreme bearish conviction — well below the 52-week high utilization of 28%, which the lending market is nowhere near now.
The analyst community has been firmly in "wait-and-see" mode. The consensus sits at Hold, with only 3 buys against 12 holds and a mean price target of $8.68 — roughly 44% above where the stock closed Monday. But that target reflects a series of cuts. Barclays trimmed to $8 in late April, and Piper Sandler lowered its target to $7 earlier in the month. The bull case rests on ZoomInfo's margin discipline — non-GAAP operating margins ran at 35.7% in FY25 and the company is guiding toward $450M in unlevered free cash flow for FY26. Bears counter that the demand environment for its go-to-market intelligence platform remains challenged, with top-line growth expectations grinding lower and customer retention still needing to prove itself. Citigroup carries a Sell rating with a $6.50 target, essentially flagging the stock as fairly valued at current levels even under a recovery scenario.
Institutional ownership adds a layer of tension. BlackRock added a substantial 16.4 million shares as of April 30, lifting its stake to 10.6% — a meaningful conviction move from the largest passive manager. Dimensional also added roughly 3 million shares. Against that, Henry Schuck, the CEO and co-founder, trimmed slightly in April. Insider selling has been modest and largely routine award-related disposals. The one prior earnings reaction in the dataset — Q4 results reported May 4 — saw the stock fall 1.4% on day one and 9.2% over the following five sessions, a reminder that the market has not been rewarding near-term beats.
Thursday's print will test whether ZoomInfo's margin story can hold without a credible top-line acceleration — and whether BlackRock's conviction is early or well-timed.
See the live data behind this article on ORTEX.
Open GTM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
